Wellington Management Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Wellington Management Group’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-49,258	Closed	-$865K	–	2376
2021 Q3	$865K	Buy	+49,258	New	+$575K	﹤0.01%	1817

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Wellington Management Group's TRIL Position: Q4 2021 in Review

Wellington Management Group sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 49,258 shares — an estimated $865K sold.

Wellington Management Group first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $865K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Wellington Management Group reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Wellington Management Group sold 49,258 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $865K.
Wellington Management Group first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Wellington Management Group's Trillium Therapeutics Inc. position peaked at $865K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Wellington Management Group's 13F filing for Q4 2021, filed 11 Feb 2022.